Lesley R. Yeung, an Associate in the Health Care and Life Sciences practice, in the firm’s Washington, DC, office, was quoted in Bloomberg BNA Health Care Daily Report, in “For Medicare’s Joint Replacement Model, a Steep Learning Curve,” by Michael Williamson.
Following is an excerpt:
Epstein Becker's Yeung noted, however, there are concerns the CJR could negatively affect some patients. In particular, the model could spur hospitals to avoid treating higher-risk patients, she said.
If some hospitals choose to not treat riskier patients, that could financially hurt those facilities in the same metropolitan statistical area that continue to see those patients, Yeung said. Hospitals that opt not to treat riskier patients would drive down the regional price for hip and knee replacements, which could make it more difficult for hospitals that provide hip and knee replacements for riskier patients to meet the target price, she explained.
Related reading:
OrthoSpineNews, 4/8/2016
